205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
13.08%
Revenue growth above 1.5x ADI's 2.98%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
21.62%
Gross profit growth above 1.5x ADI's 4.74%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
67.84%
EBIT growth above 1.5x ADI's 5.70%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
67.84%
Operating income growth above 1.5x ADI's 5.70%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
93.02%
Net income growth above 1.5x ADI's 7.40%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
88.89%
EPS growth above 1.5x ADI's 18.18%. David Dodd would review if superior product economics or effective buybacks drive the outperformance.
77.78%
Diluted EPS growth above 1.5x ADI's 20.00%. David Dodd would see if there's a robust moat protecting these shareholder gains.
0.42%
Slight or no buybacks while ADI is reducing shares. John Neff might see a missed opportunity if the company’s stock is cheap.
0.65%
Slight or no buyback while ADI is reducing diluted shares. John Neff might consider the competitor’s approach more shareholder-friendly.
2.70%
Dividend growth of 2.70% while ADI is flat. Bruce Berkowitz would see if this can become a bigger advantage long term.
107.56%
OCF growth above 1.5x ADI's 69.72%. David Dodd would confirm a clear edge in underlying cash generation.
304.55%
FCF growth under 50% of ADI's 877.55%. Michael Burry would suspect weaker operating efficiencies or heavier capex burdens.
50.60%
10Y revenue/share CAGR under 50% of ADI's 139.11%. Michael Burry would suspect a lasting competitive disadvantage.
12.73%
5Y revenue/share CAGR under 50% of ADI's 69.47%. Michael Burry would suspect a significant competitive gap or product weakness.
-2.10%
Negative 3Y CAGR while ADI stands at 36.51%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
No Data
No Data available this quarter, please select a different quarter.
273.52%
5Y OCF/share CAGR at 75-90% of ADI's 361.05%. Bill Ackman would push for operational improvements to match competitor’s mid-term gains.
99.32%
3Y OCF/share CAGR above 1.5x ADI's 28.92%. David Dodd would confirm if the firm is quickly gaining an operational edge over the competitor.
308.53%
10Y net income/share CAGR of 308.53% while ADI is zero. Bruce Berkowitz would see if minor gains can compound into a bigger lead over time.
184.44%
Below 50% of ADI's 769.09%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
29.95%
Below 50% of ADI's 104.94%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
No Data
No Data available this quarter, please select a different quarter.
87.76%
5Y equity/share CAGR at 75-90% of ADI's 113.03%. Bill Ackman might push for an improved ROE or share repurchase strategy to keep up.
60.15%
3Y equity/share CAGR at 75-90% of ADI's 76.24%. Bill Ackman pushes for margin or operational changes to match the competitor’s pace.
91.48%
Dividend/share CAGR of 91.48% while ADI is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
8.57%
Dividend/share CAGR of 8.57% while ADI is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
86.41%
3Y dividend/share CAGR of 86.41% while ADI is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
4.12%
Our AR growth while ADI is cutting. John Neff questions if the competitor outperforms in collections or if we’re pushing credit to maintain sales.
11.16%
Inventory growth well above ADI's 2.59%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
1.34%
Asset growth well under 50% of ADI's 4.42%. Michael Burry sees the competitor as far more aggressive in building resources or capacity.
4.97%
Under 50% of ADI's 38.99%. Michael Burry raises concerns about the firm’s ability to build intrinsic value relative to its rival.
-14.52%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
17.15%
R&D growth drastically higher vs. ADI's 4.60%. Michael Burry fears near-term margin erosion unless breakthroughs are imminent.
3.67%
SG&A growth well above ADI's 3.99%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.